| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.6 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.6 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.6 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |